# EDGAR Filing Document

**Accession Number:** 0001469443
**File Stem:** 0001193125-26-039882
**Filing Date:** 2026-2
**Character Count:** 2576
**Document Hash:** ae1a1b619a1ce392e4f7e042cac041de
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-039882.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0001193125-26-039882

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260205

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Arcadia Biosciences, Inc.
- **CENTRAL INDEX KEY:** 0001469443
- **STANDARD INDUSTRIAL CLASSIFICATION:** CRUDE PETROLEUM & NATURAL GAS [1311]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 810571538
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 5956 SHERRY LANE
- **STREET 2:** SUITE 2000
- **CITY:** DALLAS
- **STATE:** TX
- **BUSINESS PHONE:** 214-974-8921

**MAIL ADDRESS:**
- **STREET 1:** 5956 SHERRY LANE
- **STREET 2:** SUITE 2000
- **CITY:** DALLAS
- **STATE:** TX

Arcadia Biosciences, Inc.

5956 Sherry Lane, Suite 2000

Dallas, TX 75225

February 5, 2026

***<u>VIA EDGAR</u>***

Securities and Exchange Commission

Division of Corporation Finance

Office of Energy & Transportation

100 F Street, N.E.

Washington, D.C. 20549

Attn: Liz Packebusch, Esq.

**Re: Arcadia Biosciences, Inc.** 

 **Registration Statement on Form S-3 (No. 333-292993)**

 **Filed on January 28, 2026**

**Acceleration Request** 

 **Requested Date: February 10, 2026** 

 **Requested Time: 5:00 P.M. Eastern Time** 

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned registrant Arcadia Biosciences, Inc. (the "Company") hereby requests that the Securities and Exchange Commission take appropriate action to accelerate the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-292993) (the "Registration Statement") and declare such Registration Statement effective as of Tuesday, February 10, 2026, at 5:00 p.m., Eastern Time, or as soon thereafter as possible, or at such later time as the Company or its outside counsel, Weintraub Tobin, may orally request via telephone call to the Staff. In making this acceleration request, the Company acknowledges that it is aware of its obligations under the Securities Act of 1933, as amended.

Please direct any questions or comments concerning this request to Kevin Kelso of Weintraub Tobin, at (916) 558-6110. Also, please orally notify Mr. Kelso when the Registration Statement has been declared effective.

Very truly yours,

Arcadia Biosciences, Inc.

By: <u>/s/ Thomas J. Schaefer</u>

Name: Thomas J. Schaefer

Title: Chief Executive Officer

------